Symrise AG

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

D827A1108
SEDOL

B1JB4K8
CIK

N/A

symrise.com
LEI: 529900D82I6R9601CF26
FIGI: BBG000N4B6Z1
SY1

Symrise AG
GICS: 15101050 · Sector: Consumer goods · Sub-Sector: -
AI
PROFILER
NAME
Symrise AG
ISIN
DE000SYM9999
TICKER
SY1
MIC
XETR
REUTERS
SY1G.DE
BLOOMBERG
SY1 GR
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Fri, 21.02.2025

Press Release — Holzminden, 21 February 2025 Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC This partnership ideally complements Symrise’s current portfolio with clinically proven marine ingredients HBC, a leading manufacturer of human grade, sustainable marine proteins, collagens and oils from Norw...
Thu, 30.01.2025

 Press release — Holzminden, January 30, 2025 Preliminary financial results 2024              Organic growth of 8.7% / Group sales increase by 5.7% to around €5 billion (2023: €4.7 billion)  EBITDA of €1,033 million significantly above previous year's figure (2023: €903 million1) EBITDA margin rises to 20.7% (2023: 19.1%) Net Income increas...
Wed, 20.11.2024

Press release — Holzminden, 20 November 2024 ONE Symrise strategy to sustain continuous growth and increased focus on profitability Outlook upgraded for 2024: organic growth is now expected above 7% and EBITDA margin above 20% Long-term targets for 2028: organic sales growth at 5-7% CAGR (unchanged), EBITDA margin range specified to 21-23% (f...
Thu, 24.10.2024

Trading Statement 9M 2024Holzminden, 24 October 2024 Symrise continues strong profitable growth course   Group sales up 11.1% (organic) to €3,824 million in the first nine months, up 10.2% in the third quarter Both segments, Taste, Nutrition & Health and Scent & Care, achieved double digit growth Organic sales target expected to ...
Thu, 12.09.2024

Press release — Holzminden, September 12, 2024 Executive Board of Symrise AG reorganized Walter Ribeiro appointed Board Member for the Taste, Nutrition & Health segment Jörn Andreas leaves Symrise at his own request and on the best of terms Jean-Yves Parisot takes over as interim head of the Scent & Care segment The Supervisory Board of...
Thu, 12.09.2024

Press release — Holzminden, September 12, 2024 Executive Board of Symrise AG reorganized Walter Ribeiro appointed Board Member for the Taste, Nutrition & Health segment Jörn Andreas leaves Symrise at his own request and on the best of terms Jean-Yves Parisot takes over as interim head of the Scent & Care segment The Supervisory Board of...
Thu, 01.08.2024

Symrise on a profitable growth course in a challenging environment —         Group sales increase by 6.3 % to € 2,565 million; organic growth of 11.5 % —         EBITDA margin of 20.7 % significantly higher than the previous year —         Higher profitability due to strict cost management —         Business free cash flow more than doubled to €...
Thu, 25.04.2024

Trading Update, January – March 2024   Holzminden, Germany, April 25, 2024Symrise sees successful start into the 2024 fiscal year — Organic growth of 10.9 % — Sales growth of 5.0 % in reporting currency — Group sales increase to € 1.3 billion in the first quarter — 2024 targets and long-term targets through to 2028 confirmedSymrise AG saw a success...
Wed, 06.03.2024

Symrise AG again raises sales significantly in 2023 Group sales increase by 2.4 % to € 4,730 million (2022: € 4,618 million); organic growth of 7.9 % Adjusted EBITDA of € 903 million slightly below previous year’s figure (2022: € 922 million1]) Adjusted EBITDA margin of 19.1 % Symrise plans 14th consecutive dividend increase Symrise reaffirms ...
Thu, 29.02.2024

Holzminden, February 29, 2024 Dr Jean-Yves Parisot assumes CEO position from Dr Heinz-Jürgen Bertram - Tenure of Dr Heinz-Jürgen Bertram ends after 15 successful years as CEO - Dr Jean-Yves Parisot, an internationally experienced executive from within the company, takes over - Trustful and smooth transition until end of March 2024 ensured Dr Heinz...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S